Literature DB >> 33771803

The pathway to better primary care for chronic liver disease.

Helen Jarvis1, Stuart McPherson2, Quentin M Anstee3, Barbara Hanratty1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33771803      PMCID： PMC8007265          DOI： 10.3399/bjgp21X715553

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  17 in total

1.  Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.

Authors:  Ankur Srivastava; Ruth Gailer; Sudeep Tanwar; Paul Trembling; Julie Parkes; Alison Rodger; Deepak Suri; Douglas Thorburn; Karen Sennett; Sarah Morgan; Emmanuel A Tsochatzis; William Rosenberg
Journal:  J Hepatol       Date:  2019-04-06       Impact factor: 25.083

2.  Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care.

Authors:  John F Dillon; Michael H Miller; Emma M Robinson; Adrian Hapca; Mohsen Rezaeihemami; Christopher Weatherburn; Paul G McIntyre; Bill Bartlett; Peter T Donnan; Kathleen A Boyd; Ellie Dow
Journal:  J Hepatol       Date:  2019-06-19       Impact factor: 25.083

Review 3.  Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.

Authors:  Roger Williams; Guruprasad Aithal; Graeme J Alexander; Michael Allison; Iain Armstrong; Richard Aspinall; Alastair Baker; Rachel Batterham; Katrina Brown; Robyn Burton; Matthew E Cramp; Natalie Day; Anil Dhawan; Colin Drummond; James Ferguson; Graham Foster; Ian Gilmore; Jonny Greenberg; Clive Henn; Helen Jarvis; Deirdre Kelly; Mead Mathews; Annie McCloud; Alastair MacGilchrist; Martin McKee; Kieran Moriarty; Joanne Morling; Philip Newsome; Peter Rice; Stephen Roberts; Harry Rutter; Marianne Samyn; Katherine Severi; Nick Sheron; Douglas Thorburn; Julia Verne; Jyotsna Vohra; John Williams; Andrew Yeoman
Journal:  Lancet       Date:  2019-11-29       Impact factor: 79.321

4.  Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

Authors:  Matthew J Armstrong; Diarmaid D Houlihan; Louise Bentham; Jean C Shaw; Robert Cramb; Simon Olliff; Paramjit S Gill; James M Neuberger; Richard J Lilford; Philip N Newsome
Journal:  J Hepatol       Date:  2011-05-18       Impact factor: 25.083

Review 5.  Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.

Authors:  Roger Williams; Richard Aspinall; Mark Bellis; Ginette Camps-Walsh; Matthew Cramp; Anil Dhawan; James Ferguson; Dan Forton; Graham Foster; Ian Gilmore; Matthew Hickman; Mark Hudson; Deirdre Kelly; Andrew Langford; Martin Lombard; Louise Longworth; Natasha Martin; Kieran Moriarty; Philip Newsome; John O'Grady; Rachel Pryke; Harry Rutter; Stephen Ryder; Nick Sheron; Tom Smith
Journal:  Lancet       Date:  2014-11-29       Impact factor: 79.321

Review 6.  Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature.

Authors:  Kate Hallsworth; Leah Avery; Michael I Trenell
Journal:  Curr Gastroenterol Rep       Date:  2016-03

7.  Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.

Authors:  Ankur Srivastava; Simcha Jong; Anna Gola; Ruth Gailer; Sarah Morgan; Karen Sennett; Sudeep Tanwar; Elena Pizzo; James O'Beirne; Emmanuel Tsochatzis; Julie Parkes; William Rosenberg
Journal:  BMC Gastroenterol       Date:  2019-07-11       Impact factor: 3.067

Review 8.  Pharmacological Treatment for Non-alcoholic Fatty Liver Disease.

Authors:  Sven Francque; Luisa Vonghia
Journal:  Adv Ther       Date:  2019-03-19       Impact factor: 3.845

Review 9.  Effectiveness of brief alcohol interventions in primary care populations.

Authors:  Eileen Fs Kaner; Fiona R Beyer; Colin Muirhead; Fiona Campbell; Elizabeth D Pienaar; Nicolas Bertholet; Jean B Daeppen; John B Saunders; Bernard Burnand
Journal:  Cochrane Database Syst Rev       Date:  2018-02-24

10.  Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study.

Authors:  Lukasz Tanajewski; Rebecca Harris; David J Harman; Guruprasad P Aithal; Timothy R Card; Georgios Gkountouras; Vladislav Berdunov; Indra N Guha; Rachel A Elliott
Journal:  BMJ Open       Date:  2017-07-05       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.